Alexander Blinkovsky

This inventor holds 17 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Protein Engineering. Top assignees: Novozymes, Inc., Novozymes Biotech, Inc, Novo Nordisk Biotech, Inc.. Active years: 1997-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Blinkovsky. Retrieved from https://idiyas.com/inventor/alexander-blinkovsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 2)

% Patents Active = 58.8

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 58(Granted Patents)

Company Filing History:

Novozymes Biotech, Inc

patents

2 out of 63

Novo Nordisk Biotech, Inc.

5. 4 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2017

Loading Chart...

Areas of Expertise:

Polypeptides

Alpha-Glucosidase

Aminopeptidase

Carboxypeptidases

Polynucleotides

Protein Hydrolysates

Dipeptidyl Aminopeptidase

Nucleic Acids

Protein Solubilization

Organic Solvents

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9688973 - Polypeptides having alpha-glucosidase activity and polynucleotides encoding same (2017-06-27),

2. 8633006 - Polypeptides having alpha-glucosidase activity and polynucleotides encoding same (2014-01-21),

3. 7910804 - Polypeptides having alpha-glucosidase activity and polynucleotides encoding same (2011-03-22),

4. 7662605 - Polypeptides having alpha-glucosidase activity and polynucleotides encoding same (2010-02-16),

5. 7368271 - Polypeptides having alpha-glucosidase activity and polynucleotides encoding same (2008-05-06),

6. 7279308 - Polynucleotides encoding polypeptides having aminopeptidase activity (2007-10-09),

7. 7091002 - Carboxypeptidases and nucleic acids encoding same (2006-08-15),

8. 6951749 - Carboxypeptidases and nucleic acids encoding same (2005-10-04),

9. 6800467 - Polypeptides having aminopeptidase activity and nucleic acids encoding same (2004-10-05),

10. 6673571 - Polypeptides having aminopeptidase activity and nucleic acids encoding same (2004-01-06),

11. 6664092 - Polypeptides having dipeptidyl aminopeptidase activity and nucleic acids encoding same (2003-12-16),

12. 6465209 - Methods of producing protein hydrolysates (2002-10-15),

13. 6303360 - Polypeptides having aminopeptidase activity and nucleic acids encoding same (2001-10-16),

14. 6187578 - Carboxypeptidases and nucleic acids encoding the same (2001-02-13),

15. 6184020 - Polypeptides having aminopeptidase activity and nucleic acids encoding same (2001-02-06),

Title: The Innovative Journey of Alexander Blinkovsky

Introduction: Alexander Blinkovsky, a talented inventor based in Davis, CA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Alexander Blinkovsky holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a background in engineering and a passion for problem-solving, Alexander Blinkovsky has successfully developed and patented several cutting-edge inventions that have the potential to revolutionize their respective industries.

Collaborations: Throughout his career, Alexander Blinkovsky has collaborated with leading research institutions, universities, and tech companies to further enhance his inventions and bring them to the market, demonstrating his commitment to innovation and progress.

Conclusion: Alexander Blinkovsky's relentless pursuit of innovation and his dedication to creating solutions for complex challenges have established him as a prominent figure in the world of inventors, inspiring others to push the boundaries of what is possible in technology.

Profile summary based on public USPTO records.